Medicines Co (MDCO) Misses Q3 EPS by 3c

October 26, 2011 8:01 AM EDT
Medicines Co (NASDAQ: MDCO) reported Q3 EPS of $0.17, $0.03 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $120.8 million versus the consensus estimate of $120.37 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings